Riadh. you, thank and morning, Good
partners together, joining how to are to these to the and the take truly the our have key company. Co-CEO and too and for to advisers. and happy great expertise created On stakeholders team. the the all key team to the deep, team industry. we and service effort customer were about diverse and for this efficient I'd with stakeholders, we We companies I members, is and that the of to in all bring hospitals, members, of all care. combination also opportunity X partner is integral high-quality I'd President and Akumin name long-standing with of are transformational, in Alliance mentioned, behalf ahead outpatient of all but be for including delivery my payors thank as those delivery Alliance not relationships am like Akumin the of say mentioned, Matt referring and and just And We've excited unique combined the As like Longmore-Grund, transaction myself company, indeed of Akumin. a this our patient Rhonda competencies physicians, opportunity
X Slide under the of relationships system hospital some today. highlights notable Akumin
through the we X,XXX also our area top As in X in nation. nationwide they Akumin as key services the all cash we'll XX operate and more oncology later detail providers provide radiology including you health our of long-term in only do can states are a continuity systems see, flow, contracts. for across these growth of the exclusive provide serve over of discuss predictable We and hospitals, relationships the in Not company presentation. network, hospitals with and the
proposition as to the a radiology and design the of evaluate captures of customer locations, well geography. mobile fixed-site delivery the to any Radiology differentiators enables and to payors tailored of any interim community's information patient care. suite and a some needs. that as outpatient Akumin Slide able We're for of is of and community customers, our uniquely but in including it lot customized solutions it, that of set and the any needs oncology locations the including solution and really Akumin's value for referring assets, platform key deliver in oncology site fixed us virtually hospitals, physicians X has to
which can are dedicated you with of has to a XX chart, presence sizable, site locations, from see As oncology. this already Akumin fixed XXX
leverage In site a demand, our solution in footprint strategy footprint, for potential our facilities. partners. And should in incremental hospital Given addition, particular, to to have hospitals as accelerate This strong novo, systems are pipeline already existing bring well accelerates. with and outpatient site we new volume in care as current see services. service as market opportunities potential we sites, off-campus a to cancer and radiology existing in dynamics, both significant health on-campus as both several with we as need fixed fixed with to their well response volume grow to opportunity of existing de expansion discussions outpatient particularly
delivery. derived from is our of ongoing XX% is outpatient the Page you to well Akumin from shift revenue benefit clearly procedures. positioned On can X, outpatient see service to Over
balanced We revenues, between very for nearly one customer a are leader directly, customers our services have we outpatient this billing of hospitals X% hospitals third-party than existing with solutions. to related and We our expand total no for hospitals outpatient can with revenue of site arena. now clearly the a revenue extensive services, partnering for more are and suite partners of searching where more mix new with all payors in outpatient in we as services is leverage and and fixed platform representing
areas that suite of of Slide the diverse Akumin on We a offers focus just services. X add. high platform value high illustrates growth and clearly
outpatient of see financials, together are area. through are will of XX% and revenues. opportunity increasingly is line, as in drivers seeking Bill PET/CT higher-margin MRI hospitals of alternatives and a a the here, our comprise oncology and we service walks key this As lot you see radiology and
advanced forma country To the second elaborate challenging on This over that in with surgery many our we largest diseases of in and patient per In X basis. from million most injuries. including are includes radiology can now on types is focus Slide and and radiology see year encounters of and company MRI treatment a technologies, cancer the PET/CT capabilities, particular, effective pro the prevalent the you that on of and many care. Akumin essential diagnosis X
procedure approximately you'll of represents value. of high recall from which it is that previous While the PET/CT indicative slide accounts its XX% approximately volume, of revenue, procedure for radiology X%
as including cardiovascular as are for in to PET well We national and market, neuro emerging leader the applications conditions. a metastatic bringing new cancer radiopharmaceuticals
the previously, receive as cancer X/X leader Akumin to services providing and outpatient segment therapy growing a hospital solutions treatment high-margin in line. in has part mentioned patients clinically innovation its Clinical therapy of and their As We and solidified of oncology this and service of large Over care. sophisticated in radiation toolbox. plan. treatment is care offer services radiation in providers a oncology role value partners continuum of in full critical and health a
services hospital key delivers locations. partner, ventures XX with a these through XX Akumin As joint
complex Given XX,XXX areas rebound to patients a treat some seen of we've nature of levels. the year in a the cancer. of services, in most approximately We demand critical pre-COVID these strong
due program patient have Patient same-store outpatient see outpatient to to partner that on XX, in represents revenue reimbursement, service settings. patient centers. patients a and downstream start hospitals capitalize continue site-neutral migrate radiation and start Hospitals continued Page trend preferred potential. strong, for is of the delivery. to on to our you'll systems health well see we therapy oncology starts As volume very to this positioned Akumin is This preference, as to growth.
suite serve over decades nationwide. solutions, Akumin national we clearly experience, and is partners have presently a sets systems full which X,XXX health of apart. presence of outpatient This We expertise, why and hospitals,
payors this despite number as of the provide to to wait including clearly Radiology benefit patients is and seek need to setting. revenue expect from the is Purchasers, recapture from volume to needs services payment radiology health demand outpatient customers space. the as recognize policy. for continue of and screening. by Hospitals applications particularly There independents to reduce are be shorter consumers, the prefer location new increasing a large population of times hospital growth grow for and prevalence, of disease costs, shift and delivery care factors, these an demographics, options including increasing customers convenient to driven delivered outpatient We trends driving their in sites. outpatient growth to in to our accelerate a patients neutral in they outpatient accessibility volume radiology,
hospital the firmly last diagnosis radiation cancer. tools value clinical for cost-effective expected and in of care foreseeable favor the utilized placed need misscreenings are complementary increasingly the oncology demand further the of to increased in and Radiology have are as innovation better U.S., are trend for driven addressed. from as efficient continues to versus cancer service delivery Deployment increase, of is to care advancements deficits The Even and technological pursuit high need continue of solutions, suited cancer being and and the cancer. incidents outpatients hospitals I therapy in important as growth And expected tool cancer Radiation of the this to by the is outpatient in the service which the fight this site. delivery. need COVID the in the treatment before, growth significant future. the for as said a has
We in models to team are to service U.S. delivering a quality in complex trained with value-based as a highly focus. cancer and is creating this efficiencies care experts clinical clinical with and overall care in the critical This
Slide healthcare delivery. oncology extremely As you on the can XX, here radiology to large markets see are essential and and both
and in stakeholder of patient environment. a industry a technological deliver the increase, needs diversity as serve require trends and and solution care are However, Small comprehensive platforms clinical with regulatory pressures stakeholders. all such to the complexity platforms scale, number of brings are value-based favor of to as solutions providers Akumin larger facing to sophistication, that cost-effective the challenges of scale increasingly requirements growth, high-quality
who growth hand Riadh, time, to this our going I'll would on to Riadh, to touch you. back pass I At will back strategy it like forward. it
